Inactive Instrument

Insiders ImmunoGen, Inc.

Equities

AbbVie CEO to Retire; COO Robert Michael Named Successor	Feb. 20	MT
Immunogen, Inc. Announces Board Changes	Feb. 12	CI
ImmunoGen Insider Sold Shares Worth $352,391, According to a Recent SEC Filing	Feb. 07	MT
ImmunoGen Insider Sold Shares Worth $588,733, According to a Recent SEC Filing	Feb. 07	MT
Immunogen Insider Sold Shares Worth $5,562,450, According to a Recent SEC Filing	Jan. 19	MT
Immunogen Insider Sold Shares Worth $3,356,843, According to a Recent SEC Filing	Nov. 08	MT
Immunogen Insider Sold Shares Worth $325,153, According to a Recent SEC Filing	Nov. 08	MT
Immunogen Insider Sold Shares Worth $2,764,858, According to a Recent SEC Filing	23-10-18	MT
Immunogen Insider Sold Shares Worth $2,964,681, According to a Recent SEC Filing	23-09-19	MT
ImmunoGen Names Lauren White CFO	23-09-18	MT
Immunogen, Inc. Appoints Lauren White as Chief Financial Officer	23-09-18	CI
ImmunoGen, Inc. Announces Executive Changes	23-09-18	CI
Insider Sell: Immunogen	23-08-11	MT
Insider Sell: ImmunoGen	23-08-07	MT
Insider Sell: ImmunoGen	23-08-07	MT
Insider Sell: ImmunoGen	23-08-07	MT
ImmunoGen Chief Medical Officer Anna Berkenblit to Step Down, Successor Named	23-07-31	MT
ImmunoGen, Inc. Announces Executive Changes	23-07-31	CI
Cerevel Therapeutics Holdings Names Susan Altschuller CFO	23-05-10	MT
Immunogen, Inc. Appoints Isabel Kalofonos as Senior Vice President and Chief Commercial Officer	23-04-25	CI

No results for this search